PROLIFERATIVE EFFECTS OF CDK4 AND CDK6 DYSREGULATION
PROLIFERATIVE EFFECTS OF CDK4 AND CDK6 DYSREGULATION
批准号:
2701824
负责人:
Philip W. Hinds
金额:
$25.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2002-04-30
关键词:
cell cycle proteins cell growth regulation cell line cell proliferation cell transformation cyclin dependent kinase enzyme activity flow cytometry guanine nucleotide binding protein human tissue immunoprecipitation laboratory rat mutant neoplastic transformation northern blottings nucleic acid sequence oncoprotein p21 phosphorylation protein structure function tissue /cell culture transfection tumor suppressor proteins western blottings
中文摘要
描述:这项提议的总体目标是破译这一机制
CDK4/6的过表达可抑制P53和Rb介导的生长。在……里面
这种系统过度表达CDK4/6也导致了细胞的过度生产
细胞周期抑制物,p15,可能还有p16。通过以下方式了解该机制
P15的诱导发生是第一个特定的目标。私人侦探将
研究转录和转录后机制。此外,
不结合p15和p16的CDK4/6突变体将用于克隆
形成试验,以确定是否相互作用的激酶与
抑制剂对于推翻P53介导的生长抑制是必不可少的。这个
P21(p53的靶标)的作用也将通过p21缺失细胞来检测。
过表达温度敏感型突变体P53。在目标2中,
CDK4/6与p15和p16的相关性也将作为
PRb被磷酸化从而失活的机制
这个系统。第三个特定目标将测试CDK4/6或突变体
不结合p15和p16的基因本身可以促进永生和
或啮齿动物细胞的转化。最后,PI将确定CDK4/6是否
P15/p16结合和水解三磷酸腺苷均有缺陷的突变体
可以作为显性的负癌基因发挥作用。这个实验将会有所帮助。
确定细胞周期中需要p16/p15功能的时间点
并且可以帮助识别衬底。
英文摘要
DESCRIPTION: The overall aim of this proposal is to decipher the mechanism
by which overexpression of cdk4/6 overrides p53 and Rb mediated growth. In
this system overexpression of cdk4/6 also leads to overproduction of the
cell cycle inhibitors, p15 and possibly p16. Understanding the mechanism by
which induction of p15 occurs is the first specific aim. The PI will
examine transcriptional and post-transcriptional mechanisms. In addition,
mutants of cdk4/6 that do not bind p15 and p16 will be used in colony
formation assays to determine if the interaction of the kinases with the
inhibitors is essential for overriding p53 mediated growth suppression. The
role of p21 (a target of p53) will also be examined using p21 null cells
overexpressing the temperature sensitive p53 mutant. In aim 2, the
association of cdk4/6 with p15 and p16 will also be examined as the
mechanism by which pRB becomes phosphorylated and thereby inactivated in
this system. The third specific aim will test whether cdk4/6 or mutants
that do not bind p15 and p16 can by themselves promote immortalization and
or transformation of rodent cells. Lastly, the PI will determine if cdk4/6
mutants that are defective in both p15/p16 binding and in hydrolyzing ATP
can function as dominant negative oncogenes. This experiment will help
identify the point in the cell cycle at which p16/p15 function is required
and may aid in identification of substrates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CDK6 in T cell development and cancer
-
批准号:8007389
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:8403614
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:8214597
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7615450
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7846307
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7758353
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7680551
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7460620
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7105738
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7905946
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7893947
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7284828
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7673449
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:8116741
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7589723
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7264669
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7413461
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:6777135
-
项目类别:
-
资助金额:$42.4万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:6863760
-
项目类别:
-
资助金额:$44.2万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:7371115
-
项目类别:
-
资助金额:$47.44万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
海外基金